Polysaccharides-based nanocomplexes for the prolonged delivery of enoxaparin: In-vitro and in-vivo evaluation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International journal of pharmaceutics

• Publication date

  2017-06-30

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2017.05.007PMID 28479519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin

  2016cited by this paper
• pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation

  2016cited by this paper
• Long Acting Parenteral Formulation of Heparin

  2016cited by this paper
• Reversible controlled assembly of chitosan and dextran sulfate: a new method for nanoparticle elaboration.

  2014cited by this paper
• Effect of Synthesis Temperature on the Crystallization and Growth of In Situ Prepared Nanohydroxyapatite in Chitosan Matrix

  2014cited by this paper
• A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation

  2014cited by this paper
• Self-Titrating Anticoagulant Nanocomplexes That Restore Homeostatic Regulation of the Coagulation Cascade

  2014cited by this paper
• Elaboration of targeted nanodelivery systems based on colloidal polyelectrolyte complexes (PEC) of chitosan (CH)-dextran sulphate (DS)

  2013cited by this paper
• Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.

  2013cited by this paper
• Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.

  2013cited by this paper
• Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel

  2013cited by this paper
• Bovine serum albumin-loaded chitosan/dextran nanoparticles: preparation and evaluation of ex vivo colloidal stability in serum

  2013influential reference
• Chitosan Nanoparticles as Therapeutic Protein Nanocarriers: the Effect of pH on Particle Formation and Encapsulation Efficiency

  2013cited by this paper
• Advanced drug delivery systems for antithrombotic agents.

  2013cited by this paper
• Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance

  2012influential reference
• Thermal Analysis of Magnetic Nanoparticles Modified with Dextran

  2012cited by this paper
• Polyelectrolyte complexes of chitosan with dextran sulphate. Synthesis and characterization

  2011cited by this paper
• Colloidal polyelectrolyte complexes of chitosan and dextran sulfate towards versatile nanocarriers of bioactive molecules.

  2011cited by this paper
• Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method

  2011cited by this paper
• Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles

  2011cited by this paper
• Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation

  2011cited by this paper
• Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.

  2010influential reference
• Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism.

  2010cited by this paper
• Bioadhesion and oral absorption of enoxaparin nanocomplexes.

  2010influential reference
• Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin

  2009cited by this paper
• Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion

  2009cited by this paper
• Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction

  2008cited by this paper
• Nanoparticles - A Review

  2007cited by this paper
• Designing chitosan-dextran sulfate nanoparticles using charge ratios

  2007influential reference
• Development and characterization of new insulin containing polysaccharide nanoparticles.

  2006influential reference
• Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.

  2006cited by this paper
• Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.

  2006cited by this paper
• Venous thromboembolism and anticoagulant therapy in pregnancy.

  2005cited by this paper
• Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.

  2005cited by this paper
• Versatile and efficient formation of colloids of biopolymer-based polyelectrolyte complexes.

  2004cited by this paper
• Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide

  2003influential reference
• Care of Patients Receiving Long-Term Anticoagulant Therapy

  2003cited by this paper
• Clinical practice. Care of patients receiving long-term anticoagulant therapy.

  2003cited by this paper
• CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY

  2003cited by this paper
• In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

  2002cited by this paper
• Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery.

  2002cited by this paper
• Infrared spectroscopic study on the properties of the anhydrous form II of trehalose. Implications for the functional mechanism of trehalose as a biostabilizer.

  2001cited by this paper
• Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system.

  2000cited by this paper
• Study of the Interaction of Dextran and Enoxaparin on Haemostasis in Humans

  1994cited by this paper
• Increased circulatory half-life of liposomes after conjunction with dextran

  1984cited by this paper

• Poly(α-lipoic acid)-functionalized nanoparticles overcome dual barriers to oral heparin delivery via dynamic thiol-disulfide exchange

  2026cites this paper
• Revolutionizing Anticoagulation: Nanoengineered therapies and precision medicine approaches.

  2025cites this paper
• Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies

  2022cites this paper
• Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.

  2021cites this paper
• Synthesis and Characterization of Naringenin-Loaded Chitosan-Dextran Sulfate Nanocarrier

  2020cites this paper
• Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats

  2020cites this paper
• Preparation and In Vitro Characterization of Enoxaparin Nano-liposomes through Different Methods

  2020influential citation
• Losartan-chitosan/dextran sulfate microplex as a carrier to lung therapeutics: Dry powder inhalation, aerodynamic profile and pulmonary tolerability.

  2019cites this paper
• In situ synthesis of core-shell carbon nanowires as a potent targeted anticoagulant.

  2019cites this paper
• Development and evaluation of thermo-sensitive hydrogel system with nanocomplexes for prolonged subcutaneous delivery of enoxaparin

  2018cites this paper
• Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer.

  2018cites this paper
• An injectable in situ lipid phase transition system for sustained delivery of dabigatran etexilate with low burst release

  2017cites this paper